SD, 44 States Settle with GlaxoSmithKline

South Dakota Outline

 

PIERRE, S.D. (AP) – A multinational drugmaker is paying 45 states including South Dakota $105 million to settle complaints that the company unlawfully marketed three drugs.

South Dakota Attorney General Marty Jackley says South Dakota’s share of the settlement is nearly $1.2 million.

The settlement resolves allegations that London-based Glaxo illegally marketed Advair, Paxil and Wellbutrin for purposes that had not been approved by the Food and Drug Administration. Once the FDA approves a drug as safe and effective, a manufacturer cannot market or promote that drug for an unapproved use, a practice called off-label marketing.

The asthma treatment Advair is Glaxo’s best-selling product. Paxil and Wellbutrin are antidepressant drugs.


Comment Disclaimer: The views and opinions expressed in the comments section of DakotaRadioGroup.com are solely those of the comment author and do not necessarily reflect the views and opinions held by DakotaRadioGroup.com.

Comments are closed.


Multimedia